The Board of Directors of Spago Nanomedical Has Resolved, Subject to the Approval of the General Meeting, to Apply for Delisting From the NASDAQ First North Growth Market · Morgen-Marktbrief
The Board of Directors of Spago Nanomedical Has Resolved, Subject to the Approval of the General Meeting, to Apply for Delisting From the NASDAQ First North Growth Market
The Board of Directors of Spago Nanomedical Has Resolved, Subject to the Approval of the General Meeting, to Apply for Delisting From the NASDAQ First North Growth Market
EreignisFAKT: Belegte Information aus einer Primärquelle — z. B. veröffentlichte Zahl, offizielle Mitteilung oder Kursdaten.0/10Wichtigkeit 0 von 10
The Board of Directors of Spago Nanomedical Has Resolved, Subject to the Approval of the General Meeting, to Apply for Delisting From the NASDAQ First North Growth Market
The Board of Directors of Spago Nanomedical Has Resolved, Subject to the Approval of the General Meeting, to Apply for Delisting From the NASDAQ First North Growth Market